Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shumei Song

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Molecular Cancer|September 6, 2023
Clinically conserved genomic subtypes of gastric adenocarcinomaYun Seong Jeong, Young-Gyu Eun, Sung Hwan Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.
Ebiomedicine|October 30, 2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal CancerMasahisa Ohtsuka, Hui Ling, Cristina Ivan, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
TIM3 <sup>+</sup> Tumor Associated M2 Macrophages Impair Antitumor T Cell Immunity and Promote Gastric Cancer Progression and Peritoneal MetastasisXiaodan Yao, Yibo Fan, Junsong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinomaYuan Li, Yibo Fan, Jinbang Xu, et al.
Cancer Heterogeneity and Plasticity|July 13, 2026
YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasisJingjing Wu, Dipti Athavale, Curt Balch, et al.
Gut|January 25, 2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinomaShumei Song, Qiongrong Chen, Yuan Li, et al.
British Journal of Cancer|November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitorsJaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and MetastasesJingjing Wu, Dipti Athavale, Curt Balch, et al.
British Journal of Cancer|July 21, 2017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patientsRoopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Molecular Cancer|September 6, 2023
Clinically conserved genomic subtypes of gastric adenocarcinomaYun Seong Jeong, Young-Gyu Eun, Sung Hwan Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal CancerFan Li, Yan Xu, Bovey Liu, et al.
Ebiomedicine|October 30, 2016
H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal CancerMasahisa Ohtsuka, Hui Ling, Cristina Ivan, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
TIM3 <sup>+</sup> Tumor Associated M2 Macrophages Impair Antitumor T Cell Immunity and Promote Gastric Cancer Progression and Peritoneal MetastasisXiaodan Yao, Yibo Fan, Junsong Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2022
GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinomaYuan Li, Yibo Fan, Jinbang Xu, et al.
Cancer Heterogeneity and Plasticity|July 13, 2026
YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasisJingjing Wu, Dipti Athavale, Curt Balch, et al.
Gut|January 25, 2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinomaShumei Song, Qiongrong Chen, Yuan Li, et al.
British Journal of Cancer|November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitorsJaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and MetastasesJingjing Wu, Dipti Athavale, Curt Balch, et al.
British Journal of Cancer|July 21, 2017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patientsRoopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, et al.
Pageof 12